Efficacy and safety of favipiravir plus interferon-beta versus lopinavir/ritonavir plus interferon-beta in moderately ill patients with COVID-19: A randomized clinical trial

DOI record: { "DOI": "10.1002/jmv.27724", "ISSN": [ "0146-6615", "1096-9071" ], "URL": "http://dx.doi.org/10.1002/jmv.27724", "alternative-id": [ "10.1002/jmv.27724" ], "assertion": [ { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Received", "name": "received", "order": 0, "value": "2021-11-01" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Accepted", "name": "accepted", "order": 1, "value": "2022-03-14" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Published", "name": "published", "order": 2, "value": "2022-03-24" } ], "author": [ { "affiliation": [ { "name": "Infectious and Tropical Diseases Research Center, Hormozgan Health Institute Hormozgan University of Medical Sciences Bandar Abbas Iran" } ], "family": "Hassaniazad", "given": "Mehdi", "sequence": "first" }, { "affiliation": [ { "name": "Cardiovascular Research Center Hormozgan University of Medical Sciences Bandar Abbas Iran" } ], "family": "Farshidi", "given": "Hossein", "sequence": "additional" }, { "affiliation": [ { "name": "Social Determinants in Health Promotion Research Center, Hormozgan Health Institute Hormozgan University of Medical Sciences Bandar Abbas Iran" } ], "family": "Gharibzadeh", "given": "Abdollah", "sequence": "additional" }, { "affiliation": [ { "name": "Infectious and Tropical Diseases Research Center, Hormozgan Health Institute Hormozgan University of Medical Sciences Bandar Abbas Iran" } ], "family": "Bazram", "given": "Ali", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0001-8354-9426", "affiliation": [ { "name": "Student Research Committee Hormozgan University of Medical Sciences Bandar Abbas Iran" } ], "authenticated-orcid": false, "family": "Khalili", "given": "Elham", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Inpatient Services Iran Food and Drug Administration Tehran Iran" } ], "family": "Noormandi", "given": "Afsaneh", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-4568-7024", "affiliation": [ { "name": "Department of Pharmacology and Toxicology, Faculty of Pharmacy Hormozgan University of Medical Sciences Bandar Abbas Iran" }, { "name": "Endocrinology and Metabolic Research Center Hormozgan University of Medical Sciences Bandar Abbas Iran" } ], "authenticated-orcid": false, "family": "Fathalipour", "given": "Mohammad", "sequence": "additional" } ], "container-title": "Journal of Medical Virology", "container-title-short": "Journal of Medical Virology", "content-domain": { "crossmark-restriction": true, "domain": [ "onlinelibrary.wiley.com" ] }, "created": { "date-parts": [ [ 2022, 3, 16 ] ], "date-time": "2022-03-16T08:26:15Z", "timestamp": 1647419175000 }, "deposited": { "date-parts": [ [ 2022, 3, 24 ] ], "date-time": "2022-03-24T21:29:29Z", "timestamp": 1648157369000 }, "funder": [ { "DOI": "10.13039/501100011917", "doi-asserted-by": "publisher", "name": "Hormozgan University of Medical Sciences" } ], "indexed": { "date-parts": [ [ 2022, 4, 2 ] ], "date-time": "2022-04-02T21:06:05Z", "timestamp": 1648933565306 }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2022, 3, 24 ] ] }, "language": "en", "license": [ { "URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 3, 24 ] ], "date-time": "2022-03-24T00:00:00Z", "timestamp": 1648080000000 } }, { "URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 3, 24 ] ], "date-time": "2022-03-24T00:00:00Z", "timestamp": 1648080000000 } } ], "link": [ { "URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27724", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jmv.27724", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27724", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "311", "original-title": [], "prefix": "10.1002", "published": { "date-parts": [ [ 2022, 3, 24 ] ] }, "published-online": { "date-parts": [ [ 2022, 3, 24 ] ] }, "publisher": "Wiley", "reference": [ { "DOI": "10.1016/j.eng.2020.03.007", "doi-asserted-by": "publisher", "key": "e_1_2_10_2_1" }, { "article-title": "A prospective, randomized, open‐label trial of early versus late favipiravir therapy in hospitalized patients with COVID‐19", "author": "Doi Y", "first-page": "12", "journal-title": "Antimicrob Agents Chemother", "key": "e_1_2_10_3_1", "volume": "64", "year": "2020" }, { "article-title": "Favipiravir versus Arbidol for COVID‐19: a Randomized Clinical Trial", "author": "Chen C", "journal-title": "medRxiv", "key": "e_1_2_10_4_1", "year": "2020" }, { "DOI": "10.1016/j.biopha.2020.110825", "doi-asserted-by": "publisher", "key": "e_1_2_10_5_1" }, { "DOI": "10.1093/gerona/glx259", "article-title": "Effects of a primary care‐based multifactorial intervention on physical and cognitive function in frail, elderly individuals: a randomized controlled trial", "author": "Romera‐Liebana L", "doi-asserted-by": "crossref", "first-page": "1688", "issue": "12", "journal-title": "J Gerontol A Biol Sci Med Sci", "key": "e_1_2_10_6_1", "volume": "73", "year": "2018" }, { "DOI": "10.1080/14787210.2021.1848545", "doi-asserted-by": "publisher", "key": "e_1_2_10_7_1" }, { "article-title": "Efficacy and safety of lopinavir/ritonavir for treatment of covid‐19: a systematic review and meta‐analysis", "author": "Alhumaid S", "first-page": "4", "journal-title": "Trop Med Infect Dis", "key": "e_1_2_10_8_1", "volume": "5", "year": "2020" }, { "DOI": "10.1016/j.ijid.2020.11.008", "doi-asserted-by": "publisher", "key": "e_1_2_10_9_1" }, { "DOI": "10.1128/AAC.01061-20", "article-title": "A randomized clinical trial of the efficacy and safety of interferon β‐1a in treatment of severe COVID‐19", "author": "Davoudi‐Monfared E", "doi-asserted-by": "crossref", "first-page": "9", "journal-title": "Antimicrob Agents Chemother", "key": "e_1_2_10_10_1", "volume": "64", "year": "2020" }, { "DOI": "10.1016/j.ejps.2020.105631", "doi-asserted-by": "publisher", "key": "e_1_2_10_11_1" }, { "DOI": "10.1186/s13063-020-04747-8", "article-title": "Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID‐19: a structured summary of a study protocol for a randomized controlled trial", "author": "Hassaniazad M", "doi-asserted-by": "crossref", "first-page": "886", "issue": "1", "journal-title": "Trials", "key": "e_1_2_10_12_1", "volume": "21", "year": "2020" }, { "DOI": "10.3906/sag-2008-33", "article-title": "Treatment of SARS‐CoV‐2 pneumonia with favipiravir: early results from the Ege University cohort, Turkey", "author": "Erdem HA", "doi-asserted-by": "crossref", "first-page": "912", "issue": "3", "journal-title": "Turk J Med Sci", "key": "e_1_2_10_13_1", "volume": "51", "year": "2021" }, { "DOI": "10.1186/s12985-020-01412-z", "doi-asserted-by": "publisher", "key": "e_1_2_10_14_1" }, { "article-title": "Organizational impacts and clinical challenges of the COVID‐19 pandemic on a Swiss Tertiary Internal Medicine Department", "author": "Garnier A", "first-page": "869", "issue": "691", "journal-title": "Rev Med Suisse", "key": "e_1_2_10_15_1", "volume": "16", "year": "2020" }, { "DOI": "10.1038/s41598-021-90551-6", "doi-asserted-by": "publisher", "key": "e_1_2_10_16_1" }, { "DOI": "10.1016/j.ijid.2020.11.142", "doi-asserted-by": "publisher", "key": "e_1_2_10_17_1" }, { "article-title": "A randomized controlled study of favipiravir vs hydroxychloroquine in COVID‐19 management: what have we learned so far?", "author": "Dabbous HM", "journal-title": "Res Sq", "key": "e_1_2_10_18_1", "year": "2020" }, { "DOI": "10.1016/S2055-6640(20)30016-9", "doi-asserted-by": "publisher", "key": "e_1_2_10_19_1" } ], "reference-count": 18, "references-count": 18, "relation": {}, "resource": { "primary": { "URL": "https://onlinelibrary.wiley.com/doi/10.1002/jmv.27724" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Infectious Diseases", "Virology" ], "subtitle": [], "title": "Efficacy and safety of favipiravir plus interferon‐beta versus lopinavir/ritonavir plus interferon‐beta in moderately ill patients with COVID‐19: A randomized clinical trial", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1002/crossmark_policy" }